Treatment of Cutaneous Leishmaniasis by CO2 Laser and Er:YAG Laser

  • IMJ IMJ

Abstract

ABSTRACT


Background: Cutaneous Leishmaniasis is an endemic disease in Iraq, it persists for long periods and heals with disfiguring scars, many treatments have been suggested for this disease. Objective: To compare the effect of CO2 laser with Er:YAG laser in treatment of acute cutaneous Leishmaniasis.


Methods: This is a prospective interventional randomized, clinical study was done on 42 patients with 51 lesions in two groups evaluated in Tikrit and Baghdad city. The patients in group A underwent one session of fractional CO2 laser for treatment of cutaneous Leishmaniasis and the patients in group B underwent one session of Er:YAG laser. All cases were evaluated according to “Sharquie’s modified leishmaniasis score to assess the objective response to topical or systemic therapy”. The data collected and analyzed by Chi-square and P-value.


Results: There were 19 patients with 22 lesions in group A and 23 patients with 29 lesions in group B. The mean age was 37.4 ± 9.82. Our results show there was no statistically significant difference between cure rates of both groups. The cure rate of group A was 95.5% and that of group B was 93.2%.


Conclusions: Cutaneous Leishmaniasis can be treated effectively with CO2 laser and Er:YAG laser.


Keywords: CO2, Er:YAG, Leishmaniasis. Iraqi Medical Journal Vol. 65, No. 2, July 2019; p.167-170.

Published
2022-04-30
How to Cite
IMJ, IMJ. Treatment of Cutaneous Leishmaniasis by CO2 Laser and Er:YAG Laser. Iraqi Medical Journal, [S.l.], v. 65, n. 2, p. 1-4, apr. 2022. ISSN 0304-4564. Available at: <http://imj.edu.iq/index.php/imj/article/view/425>. Date accessed: 06 dec. 2022.
Section
Articles

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.